What is it about?
An interview about clinical cases which have inspired my research, including a case of Bechets treated with thalidomide which led to collaborations with David Sterling and Steve Thomas at Celgene which led to the development of Lenalidomide (Revlimid) and Pomalidomide. Also the first cases of melanoma treated with myco.vaccae now developed as IMM 101.
Featured Image
Why is it important?
Most clinical development is an idea developed in murine models and eventually taken into the clinic. Here the opposite has occurred with closely observed cases leading to major new drug development programmes.
Read the Original
This page is a summary of: Interview with Professor Angus Dalgleish, Immunotherapy, November 2016, Future Medicine,
DOI: 10.2217/imt-2016-0120.
You can read the full text:
Contributors
The following have contributed to this page
